## Lithium Monitoring Standards **Key Point:** Serum lithium concentration measured 12 hours post-dose (trough level) is the gold standard for therapeutic drug monitoring in lithium therapy. ### Rationale for 12-Hour Trough Level 1. **Steady-state achievement**: Lithium reaches steady state in 5–7 days; trough levels are measured at this predictable interval to avoid peak-related variability. 2. **Therapeutic window**: The accepted therapeutic range is **0.6–1.2 mEq/L** (or 0.5–1.0 mEq/L for maintenance in some guidelines). 3. **Standardization**: Trough sampling eliminates inter-individual absorption and distribution variability, making results comparable across patients and time points. ### Frequency of Monitoring | Phase | Frequency | Rationale | |-------|-----------|----------| | Initiation (first 5–7 days) | Every 2–3 days | Reach steady state; titrate dose | | Maintenance (first 6 months) | Weekly to bi-weekly | Ensure stable therapeutic level | | Long-term (> 6 months) | Every 3–6 months | Monitor for drift; assess renal/thyroid function | | After dose change | 5–7 days post-adjustment | Confirm new steady state | **High-Yield:** Toxicity risk increases sharply above 1.5 mEq/L; levels > 2.0 mEq/L are associated with severe neurotoxicity and renal damage. **Clinical Pearl:** Dehydration, NSAIDs, ACE inhibitors, and thiazide diuretics reduce lithium clearance and increase serum levels—monitor more frequently if these are co-prescribed. ### Why Other Methods Are Suboptimal - **24-hour urinary lithium**: Reflects cumulative excretion but does not correlate well with serum levels or clinical effect; not used routinely. - **Erythrocyte lithium**: Intracellular concentration; does not predict toxicity better than serum level and is cumbersome to measure. - **Salivary lithium**: Correlates with serum lithium but lacks standardization; not recommended for clinical use.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.